(19)
(11) EP 1 277 840 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
03.09.2008 Bulletin 2008/36

(45) Mention of the grant of the patent:
11.06.2008 Bulletin 2008/24

(21) Application number: 01912513.7

(22) Date of filing: 19.03.2001
(51) International Patent Classification (IPC): 
C12Q 1/06(2006.01)
 G01N 27/419(2006.01)
(86) International application number:
PCT/JP2001/002198
(87) International publication number:
WO 2001/068905 (20.09.2001 Gazette 2001/38)

(54)

Drug sensitivity measuring method

Arzneimittelansprechverhalten-Messverfahren

Méthode de mesure de la sensibilité à un médicament

(84) Designated Contracting States:
DE ES FR GB

(30) Priority: 17.03.2000 JP 2000081765

(43) Date of publication of application:
22.01.2003 Bulletin 2003/04

(73) Proprietors:
  • Jikei University School of Medicine
    Tokyo 105-0003 (JP)
  • National Institute of Advanced Industrial Science and Technology
    Chiyoda-ku, Tokyo 100-8901 (JP)
  • DAIKIN INDUSTRIES, LTD.
    Osaka-shi, Osaka 530-8323 (JP)

(72) Inventors:
  • MACHIDA, Katsuhiko
    Minato-ku Tokyo 105-0003 (JP)
  • HOSHINA, Sadayori
    Tokyo 105-0003 (JP)
  • USHIDA, Takashi Nat. Inst. Adv. Interdisciplinary
    Tsukuba-shi, Ibaraki 305-8562 (JP)
  • ARAI, Junichiro
    Tsukuba-shi Ibaraki 305-0841 (JP)
  • KATAYAMA, Hideo
    Tsukuba-shi Ibaraki 305-0841 (JP)
  • OKUMURA, Chiaki
    Tsukuba-shi Ibaraki 305-0841 (JP)
  • AMANO, Yoshihisa
    Tsukuba-shi Ibaraki 305-0841 (JP)

(74) Representative: Hofer, Dorothea et al
Prüfer & Partner GbR Patentanwälte Sohnckestrasse 12
81479 München
81479 München (DE)


(56) References cited: : 
EP-A- 0 609 458
EP-A2- 0 128 527
 EP-A- 0 632 131
JP-A- 10 276 795
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).